Where does Star Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Star Therapeutics's 3 recorded funding rounds.

Premier Alternatives

Star Therapeutics

Biotechnology · San Francisco, CA · Founded 2018 · Privately Held (backing)

Developer of antibody-based therapeutics designed to treat serious and underserved diseases through novel biological pathways. Star Therapeutics is based in San Francisco, CA and was founded in 2018. It has raised $315 million across 3 recorded rounds; the latest was a $125 million Series D in Sep 2025.

Last price · $/share

—

Implied valuation

—

Total raised

$315.0M

Last round

Later Stage VC (Series D)

Sep 2025

Cap table — not yet on record

Star Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Star Therapeutics with a free account

·The complete investor list: 19 names
·Watch Star Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Star Therapeutics

Where does Star Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Star Therapeutics's 3 recorded funding rounds.